ScripsAmerica Announces April Approved Orders of $3.5 Million

TYSONS CORNER, Va., May 6, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced April Approved Orders at Main Avenue Pharmacy of $3.5 million.

Bob Schneiderman, Chief Executive Officer and Founding Partner of ScripsAmerica, said, "Approved orders in April rebounded from a weak March. Through the first four months of the year, approved orders are on pace to exceed fiscal 2014 performance. More importantly, April approved orders were booked under our revised marketing agreements, which we expect to significantly improve Main Avenue revenues' contribution margin. In addition, in April, virtually all of our billing had been converted to our in-house system, representing another big step down in operating expenses. With preliminary estimates that we generated over $400,000 of first quarter net income under our previous marketing and billing agreements, our goal is to improve efficiencies and productivity over the course of this year to drive even more value to the bottom line for shareholders."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

CONTACT: Joe Hassett Gregory FCA 610-228-2110

Source:ScripsAmerica, Inc.